Single-cell platform tracks antibody drug delivery inside stubborn solid tumors

byVanderbilt University Medical CenterCredit: Pixabay/CC0 Public DomainArecent paperinNature Biotechnologyexamines problems and solutions for antibody-based therapies for solid pancreatic cancers and

Updated on: August 02,2026

Single-cell platform tracks antibody drug delivery inside stubborn solid tumors

byVanderbilt University Medical CenterCredit: Pixabay/CC0 Public DomainArecent paperinNature Biotechnologyexamines problems and solutions for antibody-based therapies for solid pancreatic cancers and

Updated on:August 02,2026

Simple leukemia treatment change in India cuts early child deaths

by Mike Addelman,University of ManchesterCredit: Pixabay/CC0 Public DomainA landmark Indian clinical trial has found that giving steroids in short bursts instead of continuously can halve early treatm

Updated on: August 02,2026

Simple leukemia treatment change in India cuts early child deaths

by Mike Addelman,University of ManchesterCredit: Pixabay/CC0 Public DomainA landmark Indian clinical trial has found that giving steroids in short bursts instead of continuously can halve early treatm

Updated on:August 02,2026

A single clonal starting point may explain how multiple cervical cancer subtypes arise

byUniversity de LiegeGraphical abstract. Credit:Cell Reports(2026). DOI: 10.1016/j.celrep.2026.117470How do different cancer subtypes arise? Do they originate from distinct cells, or from a single mul

Updated on: July 31,2026

A single clonal starting point may explain how multiple cervical cancer subtypes arise

byUniversity de LiegeGraphical abstract. Credit:Cell Reports(2026). DOI: 10.1016/j.celrep.2026.117470How do different cancer subtypes arise? Do they originate from distinct cells, or from a single mul

Updated on:July 31,2026

Physician experts call for systems-based approach to prostate cancer screening decisions

byUniversity of North Carolina at Chapel Hill School of MedicineCredit: Anna Tarazevich from PexelsProstate cancer screening is one of the most common decisions men face in primary care, yet many pati

Updated on: July 30,2026

Physician experts call for systems-based approach to prostate cancer screening decisions

byUniversity of North Carolina at Chapel Hill School of MedicineCredit: Anna Tarazevich from PexelsProstate cancer screening is one of the most common decisions men face in primary care, yet many pati

Updated on:July 30,2026

First‑in‑human study tests gamitrinib designed to disrupt cancer cells' energy systems

byTemple UniversityAnthony Olszanski, MD, RPh, Vice Chair of Clinical Research in the Department of Hematology/Oncology and Director of the Early Clinical Drug Development Phase 1 Program at Fox Chase

Updated on: July 28,2026

First‑in‑human study tests gamitrinib designed to disrupt cancer cells' energy systems

byTemple UniversityAnthony Olszanski, MD, RPh, Vice Chair of Clinical Research in the Department of Hematology/Oncology and Director of the Early Clinical Drug Development Phase 1 Program at Fox Chase

Updated on:July 28,2026

Can AI beat breast cancer?

by David Bradley,InderscienceCredit: Unsplash/CC0 Public DomainAn artificial intelligence (AI) system that combines breast cancer tissue images with molecular marker data achieves high accuracy in dia

Updated on: July 27,2026

Can AI beat breast cancer?

by David Bradley,InderscienceCredit: Unsplash/CC0 Public DomainAn artificial intelligence (AI) system that combines breast cancer tissue images with molecular marker data achieves high accuracy in dia

Updated on:July 27,2026

Clinical trial shows tile-based radiation therapy lowers risk of recurrence in brain metastases

byUniversity of Texas MD Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainA multicenter clinical trial led by researchers at The University of Texas MD Anderson Cancer Center has found that imp

Updated on: July 19,2026

Clinical trial shows tile-based radiation therapy lowers risk of recurrence in brain metastases

byUniversity of Texas MD Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainA multicenter clinical trial led by researchers at The University of Texas MD Anderson Cancer Center has found that imp

Updated on:July 19,2026

Why some tumors resist immunotherapy: Blocking miR-25 may help turn 'cold' cancers 'hot'

byUniversity of California - San DiegoCredit: Pixabay/CC0 Public DomainImmune checkpoint therapy, a type of cancer immunotherapy that helps the immune system recognize and attack tumors, has transform

Updated on: July 18,2026

Why some tumors resist immunotherapy: Blocking miR-25 may help turn 'cold' cancers 'hot'

byUniversity of California - San DiegoCredit: Pixabay/CC0 Public DomainImmune checkpoint therapy, a type of cancer immunotherapy that helps the immune system recognize and attack tumors, has transform

Updated on:July 18,2026

Novel prostate cancer treatment can reduce risk of disease progression by half, clinical trial shows

by Huntsman Cancer Institute at the University of UtahCredit: Artem Podrez from PexelsA Phase III clinical trial led by Neeraj Agarwal, MD, FASCO, senior director of clinical research at Huntsman Canc

Updated on: July 14,2026

Novel prostate cancer treatment can reduce risk of disease progression by half, clinical trial shows

by Huntsman Cancer Institute at the University of UtahCredit: Artem Podrez from PexelsA Phase III clinical trial led by Neeraj Agarwal, MD, FASCO, senior director of clinical research at Huntsman Canc

Updated on:July 14,2026

New theranostic approach effectively detects and treats neuroendocrine prostate cancer

by Society of Nuclear Medicine and Molecular ImagingRET-targeted PET tracer highlights neuroendocrine prostate cancer tumors. Representative PET imaging shows strong tumor uptake of the RET-binding pe

Updated on: July 10,2026

New theranostic approach effectively detects and treats neuroendocrine prostate cancer

by Society of Nuclear Medicine and Molecular ImagingRET-targeted PET tracer highlights neuroendocrine prostate cancer tumors. Representative PET imaging shows strong tumor uptake of the RET-binding pe

Updated on:July 10,2026

RAS(ON) inhibitor doubles median overall survival in patients with metastatic pancreatic cancer

byDana-Farber Cancer InstituteAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA shift in the way people think about and treat pancreatic canc

Updated on: July 06,2026

RAS(ON) inhibitor doubles median overall survival in patients with metastatic pancreatic cancer

byDana-Farber Cancer InstituteAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA shift in the way people think about and treat pancreatic canc

Updated on:July 06,2026

FDA-approved oral AML therapy could let older patients avoid monthly infusion visits

byWeill Cornell Medical CollegeCredit: Unsplash/CC0 Public DomainThe ASCERTAIN V clinical trial demonstrated that an all-oral drug combination for older patients with acute myeloid leukemia (AML) is a

Updated on: July 02,2026

FDA-approved oral AML therapy could let older patients avoid monthly infusion visits

byWeill Cornell Medical CollegeCredit: Unsplash/CC0 Public DomainThe ASCERTAIN V clinical trial demonstrated that an all-oral drug combination for older patients with acute myeloid leukemia (AML) is a

Updated on:July 02,2026